Rituxan®

Rituxan (rituximab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, thereby helping to protect healthy cells from damage. Specifically, it is a CD20-directed cytolytic antibody used for a variety of lymphomas leukemias and inflammatory conditions. Although Rituxan may be used to treat cancer it is not chemotherapy.

Other biosimilar brands of Rituximab include Ruxience (rituximab-pvvr) and Truxima (rituximab-abbs).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

Manufacturer:

Genentech

Class:

Biologics (CD20 cytolytic antibodies)

What It Treats:

  • Non-Hodgkin’s Lymphoma
  • Chronic Lymphocytic Leukemia
  • Rheumatoid Arthritis (RA)
  • Granulomatosis with Polyangiitis (GPA) (Wegener’s Granulomatosis)
  • Microscopic Polyangiitis (MPA)
  • Moderate to severe Pemphigus Vulgaris

PRESCRIBED BY:

Dermatologists Oncologists Rheumatologists

HOW ADMINISTERED:

IV infusion

FREQUENCY:

Varies widely depending on the condition being treated

Length of infusion:

Varies depending on the condition being treated

RELATED DRUGS: